Benchmarking iron dextran sensitivity: Reactions requiring resuscitative medication in incident and prevalent patients

Nephrology Dialysis Transplantation

Volumn 20, Issue 7, 2005, Pages 1438-1442

  Walters, Brian A J ^a   Van Wyck, David B ^b,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c Kidney Health Institute LLC   (United States)

Author keywords

Adverse reactions; Anaemia; Anaphylaxis; Chronic renal failure; Iron deficiency; Iron dextran

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; CORTICOSTEROID; COSMOFER; DEXIRON; ERYTHROPOIETIN; HEMOGLOBIN; IRON DEXTRAN; BRONCHODILATING AGENT; HISTAMINE H1 RECEPTOR ANTAGONIST;

ANAPHYLAXIS; ANEMIA; ARTICLE; DATA BASE; DIALYSIS; DISEASE SEVERITY; DOSE RESPONSE; DRUG EXPOSURE; DRUG HYPERSENSITIVITY; DRUG SAFETY; HUMAN; IRON DEFICIENCY; IRON THERAPY; KIDNEY FAILURE; MEDICAL RECORD; PREVALENCE; PRIORITY JOURNAL; RASH; RESUSCITATION; CHEMICALLY INDUCED DISORDER; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; RETROSPECTIVE STUDY; UNITED STATES;

ADRENAL CORTEX HORMONES; ANAPHYLAXIS; BRONCHODILATOR AGENTS; DRUG HYPERSENSITIVITY; EPINEPHRINE; HISTAMINE H1 ANTAGONISTS; HUMANS; INCIDENCE; INFUSIONS, INTRAVENOUS; IRON-DEXTRAN COMPLEX; PREVALENCE; RESUSCITATION; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 26044434869     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfh811     Document Type: Article

References (19)

1. Danielson BG. Structure, chemistry, and pharmacokinetics of intravenous iron agents. J Am Soc Nephrol 2004; 15 [Suppl 2]: S93-S98
2. Michael B, Coyne DW, Fishbane S et al. Sodium ferric gluconate complex in hemodialysis patients: Adverse reactions compared to placebo and iron dextran. Kidney Int 2002; 61: 1830-1839
3. Charytan C, Levin N, Al Saloum M, Hafeez T, Gagnon S, Van Wyck DB. Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial. Am J Kidney Dis 2001; 37: 300-307
4. Coyne DW, Adkinson NF, Nissenson AR et al. Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients. Kidney Int 2003; 63: 217-224
5. Fishbane S, Ungureanu VD, Maesaka JK, Kaupke CJ, Lim V, Wish J. The safety of intravenous iron dextran in hemodialysis patients. Am J Kidney Dis 1996; 28: 529-534
6. Fletes R, Lazarus JM, Gage J, Chertow GM. Suspected iron dextran-related adverse drug events in hemodialysis patients. Am J Kidney Dis 2001; 37: 743-749
7. Chertow GM, Mason PD, Vaage-Nilsen O, Ahlmen J. On the relative safety of parenteral iron formulations. Nephrol Dial Transplant 2004; 19: 1571-1575
8. Fishbane S, Kowalski EA, Imbriano LJ, Maesaka JK. The evaluation of iron status in hemodialysis patients. J Am Soc Nephrol 1996; 7: 2654-2657
9. Bailie GR, Johnson CA, Mason NA. Parenteral iron use in the management of anemia in end-stage renal disease patients. Am J Kidney Dis 2000; 35: 1-12
10. Sunder-Plassmann G, Horl WH. Safety aspects of parenteral iron in patients with end-stage renal disease. Drug Safety 1997; 17: 241-250
11. Van Wyck DB. Value of a test dose of iron dextran. Semin Dialysis 1999; 12: 53
12. Hamstra RD, Block MH, Schocket AL. Intravenous iron dextran in clinical medicine. J Am Med Assoc 1980; 243: 1726-1731
13. Hamstra RD, Block MH, Schocket AL. Intravenous iron dextran in clinical medicine. J Am Med Assoc 1980; 243: 1726-1731
14. Wallerstein RO. Intravenous iron-dextran complex. Blood 1968; 32: 690-695
15. Folkert VW, Michael B, Agarwal R et al. Chronic use of sodium ferric gluconate complex in hemodialysis patients: Safety of higher-dose (> or =250 mg) administration. Am J Kidney Dis 2003; 41: 651-657
16. Michael B, Coyne DW, Folkert VW, Dahl NV, Warnock DG. Sodium ferric gluconate complex in haemodialysis patients: A prospective evaluation of long-term safety. Nephrol Dial Transplant 2004; 19: 1576-1580
17. McCarthy JT, Regnier CE, Loebertmann CL, Bergstralh EJ. Adverse events in chronic hemodialysis patients receiving intravenous iron dextran - a comparison of two products. Am J Nephrol 2000; 20: 455-462
18. SECTION III. Treatment of renal anaemia. Nephrol Dial Transplant 2004; 19: II16-II31
19. IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000. Am J Kidney Dis 2001; 37: S182-S238